Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

188.87 -0.18 (-0.10%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout
Thousand Oaks, CA – October 31, 2025 – Amgen (NASDAQ: AMGN), a leading biotechnology giant, has declared a quarterly dividend of $2.38 per share for the fourth quarter of 2025. This significant... 
Via MarketMinute
Topics Intellectual Property
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of... 
Via TokenRing AI
Topics Artificial Intelligence Supply Chain
AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine
Artificial intelligence (AI) is ushering in a transformative era for pharmaceutical research and development (R&D), fundamentally reshaping how new medicines are discovered, developed, and brought to... 
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late... 
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Via MarketBeat
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush. 
Via Benzinga
Topics ETFs
Navigating the Aftermath: What Lies Ahead for Markets Post-Decline
The financial markets are grappling with the reverberations of a significant day of declines, leaving investors and analysts alike pondering the immediate and long-term trajectory. This recent downturn... 
Via MarketMinute
Topics Economy Stocks
From Record Heights to Pullback: Analyzing the Current Market Correction
The global financial markets, which had soared to unprecedented valuations through late 2024 and early 2025, experienced a sharp and unsettling correction in April 2025. This significant downturn,... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
S&P 500 Healthcare Sector Navigates Mixed Market Waters on October 29, 2025
On October 29, 2025, the broader market exhibited a decidedly mixed performance, reflecting a prevailing sense of uncertainty among investors. Against this backdrop of fluctuating sentiment, the S&P... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Navigating the Aftermath: Market Outlook Post-Declines Amidst Trade Truce and Rate Uncertainty
The global financial markets, as of October 30, 2025, are grappling with a complex interplay of factors, following a day characterized by stock futures pointing to a lower open and investor caution.... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
S&P 500: Decoding the Daily Market Pulse on October 29, 2025
As the trading day of October 29, 2025, draws to a close, investors and analysts alike are keenly focused on the S&P 500, the bellwether index for the U.S. stock market. Representing 500 of the largest... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Market Mania: Soaring Investor Confidence Propels Global Indices to Uncharted Heights
As October 29, 2025, dawns, financial markets are awash with an extraordinary wave of investor confidence, a sentiment so potent it is propelling major global indices to unprecedented record highs.... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Navigating the Financial Tides: An Investor's Timeless Guide to Bull and Bear Markets
In the dynamic world of financial markets, two iconic figures dominate the landscape: the Bull and the Bear. These powerful symbols represent the contrasting forces that drive asset prices, investor... 
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Bonds
Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women. 
Via Benzinga
Topics Lawsuit
Kenvue Stock Drops After Texas Attorney General Sues Company Alleging Deceptive Marketing Of Tylenol
The lawsuit comes on the heels of President Trump linking Tylenol to autism. 
Via Stocktwits
Topics Government Lawsuit
2 Dividend Stocks to Double Up on Right Now
They are about as safe as dividends can get. 
Via The Motley Fool
Topics Artificial Intelligence Economy
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Market Alarms Blare: Buffett Indicator and Shiller CAPE Ratio Signal Potential 2026 Stock Market Crash
As the calendar turns towards late 2025, prominent valuation metrics, the "Buffett Indicator" and the "Shiller CAPE Ratio," are flashing crimson, sending strong signals of a potentially significant... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Market's Perilous Peak: Is the U.S. Stock Market More Overvalued Than Ever?
New York, NY – October 27, 2025 – A chorus of concern is growing louder across financial markets, with prominent voices like MarketWatch raising alarm bells over what they describe as an unprecedented... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Dow Jones Soars to New Record High Amidst Wave of Optimism, Signaling Robust Market Confidence
The Dow Jones Industrial Average (DJIA) recently achieved a significant milestone, surging by over 200 points to close at an unprecedented all-time record high in October 2025. This remarkable ascent... 
Via MarketMinute
Topics Artificial Intelligence Economy Energy
3 Healthcare Stocks to Buy Hand Over Fist in October
One growth stock, one high-yield stock, and one Dividend King -- you should find something you like here as October draws to a close. 
Via The Motley Fool
Topics Intellectual Property
Warren Buffett's Investing Playbook -- Simplified for First-Time Stock Buyers
Want to invest like Buffett? You don't need billions of dollars -- just a long-term mindset and the discipline to stay consistent. 
Via The Motley Fool
Topics Economy
3 Healthcare Stocks Paying the Highest Dividends of 2025
If you are looking for high yields in the healthcare sector, here are three choices. Make sure you understand the risks before you buy them. 
Via The Motley Fool
Market Minute: Dow Hits Record Highs, S&P 500 Surges Past 6,800 as Inflation Cools
October 24, 2025 – The U.S. stock market experienced an electrifying day of trading, with major indices soaring to unprecedented levels. The Dow Jones Industrial Average (DJIA) shattered previous... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Economic Data Blackout: Government Shutdown Casts Shadow Over Market Clarity
Washington D.C., October 24, 2025 – As the U.S. federal government enters its 24th day of an ongoing shutdown, a critical "economic data blackout" is increasingly clouding the financial landscape. The... 
Via MarketMinute
Topics Economy Stocks
FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep
FDA approves GSK's Blenrep combo for relapsed multiple myeloma, showing 51% reduced death risk and tripled progression-free survival in Phase 3 trial. 
Via Benzinga
IMF Sounds Alarm: 'Shifting Ground Beneath the Calm' Threatens Global Financial Stability
Washington D.C. – October 23, 2025 – The International Monetary Fund (IMF) has today released its Global Financial Stability Report (GFSR) for October 2025, titled "Shifting Ground beneath the Calm,"... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Flash PMI: The Early Warning System Guiding the Federal Reserve's Hand
Flash Purchasing Managers' Index (PMI) data, a critical economic bellwether, continues to command significant attention from financial markets and policymakers alike. Released typically a week or two... 
Via MarketMinute
Topics Bonds Economy Supply Chain
Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares... 
Via MarketMinute
Topics Earnings Supply Chain
Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence
San Francisco, CA – October 22, 2025 – Nurix Therapeutics (NASDAQ: NRIX) has captured significant market attention, with its stock experiencing a notable surge following the announcement of the... 
Via MarketMinute
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.